Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.4900 (-0.35%) ($8.3400 - $8.6500) on Tue. Feb. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 37 | Latest Price | $8.4900(-0.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(5%) IBB(3%) TBT(3%) BLOK(2%) KWEB(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.885% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
1 - 5 Day Possible Target | $3.84(-54.77%) | Resistance Level | $8.87 | 5 Day Moving Average | $8.74(-2.86%) | 10 Day Moving Average | $8.85(-4.07%) | 20 Day Moving Average | $8.87(-4.28%) | To recent high | -12.7% | To recent low | 20.3% | Market Cap | $1.498b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |